ARCHIVES

Clinical Trials Approved In August 2002 By NCI

This article is from The Cancer Letter archive.

Vol. 25 No. 9 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

ACS President Calls On Physicians To Take Advantage Of “Untapped Opportunities” In Cancer Prevention

March 27, 1987

NCI Funds Proteomic Technology Assessment Grants.

September 29, 2006

ADT May Increase Risk Of Cardio Events In Prostate Cancer Patients

February 5, 2010

Recombinant TSH Avoids Need To Stop Replacement Therapy

January 27, 2006

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998

FDA Lacks Resources To Deal With Onslaught Of New Cancer Drugs, Friedman Tells Agency

August 14, 1992